Key result
Moderate to severe rejection after heart transplantation was associated with significantly increased endothelial cell binding of Pal-E and F VIII-related antigen compared to other cardiac conditions.
Why the study?
Does binding of endothelial-specific antibodies differ in myocarditis, dilated cardiomyopathy, and heart transplant rejection compared to normal donor hearts?
Population
Endomyocardial biopsies from patients with myocarditis, dilated cardiomyopathy, no clinical rejection after…
Comparison
Staining with monoclonal endothelial-specific… vs 'Normal' donor hearts
Design
Cross-sectional
Authors
Loading...
Endothelial antigen binding may mark severe rejection; leaves open whether these markers aid monitoring or therapy.
Cross-Sectional (n=56)
Does binding of endothelial-specific antibodies differ in myocarditis, dilated cardiomyopathy, and heart transplant rejection compared to normal donor hearts?
Endothelial cells show increased expression of specific antigens during heart transplant rejection, suggesting they are important targets in the rejection process.
Hengstenberg et al. (1991) conducted a cross-sectional in Myocarditis, dilated cardiomyopathy, and heart transplantation rejection (n=56). Moderate to severe rejection after heart transplantation vs. Myocarditis, dilated cardiomyopathy, no clinical rejection, and normal donor hearts was evaluated on Binding of monoclonal endothelial-specific antibodies EN4, Pal-E and F VIII-related antigen. Moderate to severe rejection after heart transplantation was associated with significantly increased endothelial cell binding of Pal-E and F VIII-related antigen compared to other cardiac conditions.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: